Moreover, recent studies demonstrated that the circadian clock influences therapeutic outcomes in a number of diseases including heart disease and cancer [3–9], and that disruption of the normal circadian rhythm and sleep (e.g., through shift work) is associated with a higher risk of obesity, hypertension, diabetes, chronic heart disease, stroke and cancer [10–13]. This evidence concerns the gene CLOCK and cancer.